9 EyeWorld Asia Pacific | June 2024 About the Physicians D. Brian Kim, MD | Professional Eye Associates, Dalton, Georgia | docdbk100@gmail.com Rony Sayegh, MD | Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio | rrs109@case.edu Reference 1. Kim ME, Kim DB. Implementation of the corneal sweep test in the diagnosis of recurrent corneal erosion: a 2-year retrospective study. Cornea. 2022;41:1248–1254. This article originally appeared in the March 2024 issue of EyeWorld. It has been slightly modified and appears here with permission from the ASCRS Ophthalmic Services Corp. Relevant Disclosures Kim: None Sayegh: None Both Dr. Sayegh and Dr. Kim describe cataract surgery as a common contributor to FBS, providing valuable perspectives on the challenges encountered by patients and ophthalmologists during the postoperative period. By delving into potential mechanisms such as local oedema, inflammation, and nerve damage, Dr. Sayegh illuminates the interplay between surgical trauma and the integrity of the ocular surface. His analysis astutely underscores the importance of recognising predisposing factors and implementing targeted interventions to effectively manage postoperative FBS, thereby improving patient satisfaction and ocular comfort. I also agree with Dr. Kim who points out that Betadine and topical medications likely also play a role. While the exploration of FBS aetiology is intellectually stimulating, we should acknowledge that patients primarily seek relief from their symptoms. Despite the complexity of underlying causes, the armamentarium of treatment options remains relatively unchanged. Unpreserved lubricants, topical steroids, and/or cyclosporine, coupled with patience, constitute the cornerstone of management. It is crucial for Ophthalmologists to convey to their cataract surgery patients that FBS is a common and expected phenomenon postoperatively. I often liken it to the healing process of a cut or graze on the skin, explaining that as the ASIA-PACIFIC PERSPECTIVES Jacqueline Beltz, MD 2/232 Victoria Parade, East Melbourne, Vic 3002 Australia jacquelinebeltz@mac.com eye undergoes repair, sensations of dryness or itchiness will arise but can be alleviated with time and supportive treatments. Setting realistic patient expectations is paramount in managing postoperative FBS. By providing reassurance and explaining the transient nature of these symptoms, we can mitigate patient anxiety and improve adherence to treatment regimens. While persistent FBS beyond three months poses a clinical challenge, I do not find the incidence to be as high as 10-15% as described by Dr. Sayegh. Timely recognition of refractory cases is important as it allows for further investigation, management, and most importantly, patient support. By integrating clinical expertise with patient-centred care, Ophthalmologists can navigate the complexities of FBS aetiology while prioritising symptom relief and enhancing patient well-being. As we continue to refine our understanding and therapeutic approaches, collaboration and dialogue within the ophthalmic community will undoubtedly drive advancements in postoperative care and improve patient outcomes. Editors’ note: Dr. Jacqueline Beltz is a consultant for Alcon, Johnson and Johnson, and Acufocus. CATARACT
RkJQdWJsaXNoZXIy Njk2NTg0